SLS BIO Co., Ltd (KOSDAQ: 246250)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,065.00
+10.00 (0.25%)
Sep 11, 2024, 11:30 AM KST
-60.07%
Market Cap 56.95B
Revenue n/a
Net Income n/a
Shares Out 13.66M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,535,581
Open 4,100.00
Previous Close 4,055.00
Day's Range 4,020.00 - 4,410.00
52-Week Range 2,325.00 - 10,180.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About SLS BIO

SLS BIO Co., Ltd develops diagnostic technologies in South Korea. It offers pharmaceuticals quality control testing services, including pharmaceutical equivalence study, raw materials/finished drugs test, and other analysis testing services; and efficacy evaluation services, such as immune function-based efficacy evaluation and pharmacokinetics and toxicokinetics analysis services. In addition, it provides diagnostic kits comprising rapid allergy test, rapid bovine pregnancy diagnosis, and horse individual forensic kits, as well as nano-bio tec... [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246250
Full Company Profile

News

There is no news available yet.